Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    InMed Pharmaceuticals Inc...

    NASDAQ: INM · Real-Time Price · USD
    2.50
    -0.19 (-7.06%)
    At close: Jun 13, 2025, 3:59 PM
    2.50
    -0.08%
    After-hours: Jun 13, 2025, 05:42 PM EDT

    InMed Pharmaceuticals Statistics

    Share Statistics

    InMed Pharmaceuticals has 1.21M shares outstanding. The number of shares has increased by -85.56% in one year.

    Shares Outstanding

    n/a
    		 1.21M

    Shares Change (YoY)

    n/a
    		 -85.56%

    Shares Change (QoQ)

    n/a
    		 66.7%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 1.2M

    Failed to Deliver (FTD) Shares

    n/a
    		 9,047

    FTD / Avg. Volume

    n/a
    		 0.69%

    Short Selling Information

    The latest short interest is 49.61K, so 4.11% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 49.61K

    Short % of Shares Out

    n/a
    		 4.11%

    Short % of Float

    n/a
    		 4.12%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -4.99 and the forward PE ratio is null. InMed Pharmaceuticals's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -4.99

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 8.34

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 4.16

    P/FCF Ratio

    n/a
    		 -5.48

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for InMed Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 4.41

    Quick Ratio

    n/a
    		 3.78

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.14

    Debt / FCF

    n/a
    		 -0.14

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $353,671.54

    Profits Per Employee

    n/a
    		 $-590,426.92

    Employee Count

    n/a
    		 13

    Asset Turnover

    n/a
    		 0.39

    Inventory Turnover

    n/a
    		 2.81

    Taxes

    Income Tax

    n/a
    		 7.1K

    Effective Tax Rate

    n/a
    		 -0.09%

    Stock Price Statistics

    The stock price has increased by -43.79% in the last 52 weeks. The beta is 0.28, so InMed Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.28

    52-Week Price Change

    n/a
    		 -43.79%

    50-Day Moving Average

    n/a
    		 2.74

    200-Day Moving Average

    n/a
    		 3.95

    Relative Strength Index (RSI)

    n/a
    		 47.39

    Average Volume (20 Days)

    n/a
    		 1,319,228

    Income Statement

    In the last 12 months, InMed Pharmaceuticals had revenue of 4.6M and earned -7.68M in profits. Earnings per share was -1.01.

    Revenue

    n/a
    		 4.6M

    Gross Profit

    n/a
    		 1.1M

    Operating Income

    n/a
    		 n/a

    Net Income

    n/a
    		 -7.68M

    EBITDA

    n/a
    		 -7.06M

    EBIT

    n/a
    		 -8.13M

    Earnings Per Share (EPS)

    n/a
    		 -1.01
    Full Income Statement

    Balance Sheet

    The company has 6.57M in cash and 962.66K in debt, giving a net cash position of 5.61M.

    Cash & Cash Equivalents

    n/a
    		 6.57M

    Total Debt

    n/a
    		 962.66K

    Net Cash

    n/a
    		 5.61M

    Retained Earnings

    n/a
    		 -109.08M

    Total Assets

    n/a
    		 9.28B

    Working Capital

    n/a
    		 4.57B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -6.99M and capital expenditures -9.29K, giving a free cash flow of -7M.

    Operating Cash Flow

    n/a
    		 -6.99M

    Capital Expenditures

    n/a
    		 -9.29K

    Free Cash Flow

    n/a
    		 -7M

    FCF Per Share

    n/a
    		 -0.92
    Full Cash Flow Statement

    Margins

    Gross margin is 23.94%, with operating and profit margins of 0% and -166.94%.

    Gross Margin

    n/a
    		 23.94%

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 -166.79%

    Profit Margin

    n/a
    		 -166.94%

    EBITDA Margin

    n/a
    		 -153.64%

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 -152.14%

    Dividends & Yields

    INM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for INM.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 14, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Nov 14, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -18.07

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist